Project Grant R03EB037729
- This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...
- This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant award of $275,000 to Adialante L.L.C. focuses on the development of techniques to facilitate the design and fabrication of affordable, compact, and patient-friendly magnetic resonance imaging (MRI) systems, particularly for pediatric applications. The project aims to innovate novel B1 imaging approaches, such as Frequency-Encoded and Phase-Encoded Frequency-Modulated Rabi-Encoded Echoes (FREE), that...
- This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...
- This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $642,000 to develop an automated assessment pipeline for evaluating peripherally inserted central catheters (PICCs) in pediatric chest radiographs using deep learning algorithms. The goal is to create an accurate, robust, and clinically available tool to automatically...
- This Project Grant award, valued at $507,718.03 and awarded on December 9, 2024, was provided by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Cedars-Sinai Medical Center to conduct research on "Non-Contrast 3D T1ρ Mapping for Myocardial Fibrosis Quantification of Pediatric Cardiomyopathy Patients." The research aims to develop a non-contrast cardiac MRI technique that can accurately detect and quantify myocardial fibrosis in pediatric...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $408,400 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop and assess a wearable magnetoencephalography (MEG) system for use in children. The project aims to design age-matched MEG helmets that can accommodate variable pediatric head sizes and develop...
- This $323,230 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development of a multi-channel radiofrequency and pulsed field energy source generator for cardiac ablation procedures. The award recipient, Sirona Medical Technologies, Inc., is developing a novel catheter device and customizable energy generator to improve the safety and precision of cardiac ablation treatments. Key product features include...
- This Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to significantly enhance quantitative magnetic resonance imaging (MRI) technology for in-vivo analysis of neurovascular structures and the early developing brain's response to perinatal stroke. The $511,583 award, with a project period from August 1, 2025 to May 31,...
- This Cooperative Agreement award from the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) provides $808,070 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a novel head-neck imaging system for comprehensive neurological MRI exams at 7 Tesla. The project aims to create a 16-channel transmit/64-channel receive radiofrequency coil...
- This $397,034 Project Grant awarded by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to the Massachusetts Institute of Technology (MIT) on September 1, 2025 supports the development of a Transcatheter Manufacturing Toolkit for Minimally-Invasive and Patient-Specific Device-Based Stroke Prevention. The key product being developed under this grant is a system to create fully-soft, personalized medical implants directly inside the patient's body in a...
VERTICAL MRI FOR SAFE IMAGING OF CHILDREN WITH CARDIAC DEVICES - ABSTRACT INFANTS AND CHILDREN WITH CONGENITAL HEART DEFECTS (CHD), INHERITED ARRHYTHMIA SYNDROMES, AND CONGENITAL DISORDERS OF CARDIAC CONDUCTION OFTEN REQUIRE CARDIAC IMPLANTABLE ELECTRONIC DEVICES (CIEDS). SOME INFANTS RECEIVE A CIED WITHIN HOURS, OR EVEN MINUTES, OF BIRTH. SINCE INTRAVENOUS ACCESS TO HEART IN YOUNG PATIENTS IS LIMITED BY THE SMALL VEIN SIZE, THE OPTIMAL APPROACH TO AFFIXING A CIED TO THE HEART OF SUCH PATIENTS IS TO OPEN THE CHEST AND SEW THE CARDIAC LEAD DIRECTLY TO THE MYOCARDIUM ("EPICARDIAL LEADS") AS OPPOSED TO PASSING IT THROUGH VEINS AND AFFIX TO THE INSIDE OF THE HEART ("ENDOCARDIAL LEADS"). UNFORTUNATELY, ONCE EPICARDIAL LEADS HAVE BEEN IMPLANTED, THE PATIENT IS NO LONGER ELIGIBLE TO RECEIVE MAGNETIC RESONANCE IMAGING (MRI) EXAMS. THIS IS BECAUSE ELECTRIC FIELDS PRODUCED BY THE MRI MACHINE CAN INTERACT WITH IMPLANTED LEADS, CAUSING EXCESSIVE TISSUE HEATING AND POTENTIAL THERMAL INJURIES. MR-CONDITIONAL CIEDS WITH ENDOCARDIAL LEADS HAVE BEEN APPROVED BY THE FDA, BUT NO EQUIVALENT SYSTEM EXISTS FOR CHILDREN WITH EPICARDIAL LEADS. THIS LEAVES THE MOST VULNERABLE PATIENT POPULATION UNABLE TO RECEIVE THE STANDARD OF CARE THAT THEY NEED THE MOST, AS CHILDREN WITH HEART DISEASE OFTEN REQUIRE COMPLEX CLINICAL DECISION MAKING WHICH HIGHLY BENEFITS FROM MRI'S SENSITIVITY AND ACCURACY. THE PROBLEM IS EXACERBATED BY THE FACT THAT THERE IS NO STRAIGHTFORWARD METHOD TO EXTRACT EPICARDIAL LEADS, SO CHILDREN WHO RECEIVE THESE LEADS ARE EXCLUDED FROM BENEFITS OF MRI FOR LIFE, EVEN IF AN FDA-APPROVED ENDOCARDIAL SYSTEM IS LATER PLACED WHEN THEY ARE OLDER. THIS FORCES CLINICIANS TO RESORT TO CT AND X-RAY IMAGING, WHICH NOT ONLY PRODUCE SUB-OPTIMAL IMAGES BUT ALSO EXPOSE THE YOUNG CHILDREN TO SIGNIFICANT DOSES OF IONIZING RADIATION, INCREASING THEIR LIFETIME RISK OF CANCER. OUR LONG-TERM GOAL IS TO MAKE MRI TECHNOLOGY FULLY ACCESSIBLE TO CHILDREN WITH CIEDS. HERE WE PROPOSE TO TEST THE HYPOTHESIS THAT VERTICAL MRI SCANNERS WITH A 90 ROTATED RF FIELD ORIENTATION GENERATE SUBSTANTIALLY LESS RF HEATING AROUND LEADS OF EPICARDIAL CIEDS WITH REALISTIC AND CLINICALLY RELEVANT CONFIGURATIONS. OUR HYPOTHESIS IS BASED ON OUR SIMULATION STUDIES (UNPUBLISHED) OF A COMMERCIALLY AVAILABLE VERTICAL MRI COIL (OASIS, FUJIFILM), WHICH GENERATED A 700% LESS LOCAL SPECIFIC ABSORPTION RATE (SAR) OF ENERGY DEPOSITION AT THE TIPS OF EPICARDIAL LEADS IN A PEDIATRIC PATIENT MODEL COMPARED TO THE STATUS-QUO QUADRATURE BIRDCAGE BODY COIL. AT PRESENT, THERE IS HIGHLY LIMITED LITERATURE AVAILABLE ON CIED SAR SPECIFICALLY FOR VERTICAL MRI SCANNERS. WE WILL DEVELOP A VIRTUAL FAMILY OF PEDIATRIC PATIENT MODELS WITH TRAJECTORIES OF BOTH EPICARDIAL AND ENDOCARDIAL LEADS. WE WILL ALSO DEVELOP AND EXPERIMENTALLY VALIDATE ISO/TS 10974 STANDARD COMPLIANT ACTIVE IMPLANTABLE MEDICAL DEVICE (AIMD) MODEL OF THE IMPLANTS BASED ON TRANSFER FUNCTION METHODS AND USE THE MODEL TO PREDICT RF HEATING DURING MRI IN 1.2 T VERTICAL SYSTEMS (UNLABELED) AND COMPARE TO RF HEATING OF ENDOCARDIAL CIEDS IN HORIZONTAL SYSTEMS AT 1.5 T (LABELED). BASED ON THE RESULTS, WE WILL DEVELOP LOOKUP TABLES TO SELECT IMAGING PARAMETERS THAT CONSTRAIN RF HEATING TO CLINICALLY SAFE LEVELS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $85.1k | 9/3/25 |